Half-year report · Q2
2503.TEDINET S100U68G
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.10T | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.13T | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥970.2bn | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥80.9bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥36.9bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥108.5bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥197.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥57.1bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥57.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥112.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥32.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥74.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥41.8bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥3.13T | at 2024-06-30 | Cons. | Assets IFRS |
| Total assets | ¥2.87T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.60T | at 2023-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.55T | at 2024-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.44T | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.59T | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.43T | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.33T | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.25T | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.29T | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.13T | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.06T | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥138.4bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥131.4bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥140.0bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥88.1bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥108.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥203.2bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥58.9bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥116.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥226.1bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥56.0bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥21.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥35.9bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥15.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥139.16 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥39.5 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥139.15 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥39.49 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 41.2% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.5% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.8% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥45.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥34.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥331m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥26.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥513.7bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥512.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥50.3bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥71.1bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥69.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥271.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥270.0bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥30.1bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥233.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥232.8bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥132m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥41.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-06-30 | ¥44.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-06-30 | ¥13.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥31.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥435m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥36.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥36.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥24.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥482.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥480.9bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥45.0bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥38.0bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥36.2bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥4.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥242.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥241.0bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥23.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥199.2bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥199.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥210m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥36.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 831
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from sale of shares of subsidiaries inv cf IFRS | CurrentYTDDuration | － | JPY |
| Purchase of investments accounted for using equity method inv cf IFRS | Prior1YTDDuration | -18000000 | JPY |
| Purchase of investments accounted for using equity method inv cf IFRS | CurrentYTDDuration | -5000000 | JPY |
| Proceeds from sale of investments accounted for using equity method inv cf IFRS | Prior1YTDDuration | 42000000 | JPY |
| Proceeds from sale of investments accounted for using equity method inv cf IFRS | CurrentYTDDuration | － | JPY |
| Other inv cf IFRS | Prior1YTDDuration | 697000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | -3288000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -55978000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | -116025000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | Prior1YTDDuration | -179000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | CurrentYTDDuration | 491000000 | JPY |
| Increase decrease in commercial paper fin cf IFRS | Prior1YTDDuration | 72000000000 | JPY |
| Increase decrease in commercial paper fin cf IFRS | CurrentYTDDuration | 20000000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | Prior1YTDDuration | 50272000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | CurrentYTDDuration | 103432000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | Prior1YTDDuration | -31678000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | CurrentYTDDuration | -53646000000 | JPY |
| Redemption of bonds fin cf IFRS | Prior1YTDDuration | -30000000000 | JPY |
| Redemption of bonds fin cf IFRS | CurrentYTDDuration | － | JPY |
| Payment for redemption of bonds with subscription rights to shares fin cf IFRS | Prior1YTDDuration | － | JPY |
| Payment for redemption of bonds with subscription rights to shares fin cf IFRS | CurrentYTDDuration | -9621000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -8552000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -9398000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1YTDDuration | -12000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | CurrentYTDDuration | -22000000 | JPY |
| Purchase of treasury stock of subsidiaries in consolidation fin cf IFRS | Prior1YTDDuration | -6000000 | JPY |
| Purchase of treasury stock of subsidiaries in consolidation fin cf IFRS | CurrentYTDDuration | -27047000000 | JPY |
| Decrease increase in deposits for purchase of treausury shares of subsidiaries fin cf IFRS | Prior1YTDDuration | － | JPY |
| Decrease increase in deposits for purchase of treausury shares of subsidiaries fin cf IFRS | CurrentYTDDuration | -8959000000 | JPY |
| Dividends paid fin cf IFRS | Prior1YTDDuration | -29559000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYTDDuration | -29560000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | Prior1YTDDuration | -6713000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | CurrentYTDDuration | -7215000000 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | 3000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | -22000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | 15577000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -21568000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 7920000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 35889000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1YTDDuration | 26444000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | CurrentYTDDuration | 7008000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 88060000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 131399000000 | JPY |
| Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRS | Prior1YTDDuration | 25484000000 | JPY |
| Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRS | CurrentYTDDuration | － | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 139988000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 138406000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember | 480922000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember | 241011000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember | 198999000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |